All News
View More
5 Priorities for Managed Care

Opinion piece on the top 5 priorities for managed care by Managed Healthcare Executive Editorial Advisory Board Member, Don Hall, M.P.H.,principal of DeltaSigma, LLC.

Fatigue is Nearly Universal with MPNs, But Patients Report Lack of Guidance on How to Manage It

Interviews with people with myeloproliferative neoplasms show almost all of them often feel fatigued — and that they must manage the problem on their own.

Genetic Factors May Predispose People with MPNs to Cardiovascular Events

The new report is believed to be among the first to examine cardiovascular risk in myeloproliferative neoplasms through a genetic lens. Mutations in the CALR gene may restore vascular dysfunction in some patients.

The Oncology Care Model Provides a Framework for the New Enhancing Oncology Model

The new model starts in July 2023. Practices will be required to take on two-sided risk right from the start.

FDA Updates for the Week of August 8, 2022

In a busy week, the FDA has approved additional indications for Enhertu, Myfembree and Nubeqa, as well as a tablet form of Calquence. The agency also approved Xofluza for children, issued an EUA for monkeypox vaccine in children, extended the review of omaveloxolone, set up advisory committee meeting for microbiota-based C. diff therapy, and priority review for elacestrant in breast cancer. Additionally, Novaliq submited NDA for dry eye treatment.

Biomarkers for Graft-Versus-Host Disease | Part 3

Biomarkers may help identify acute graft-versus-host disease patients who could be treated with alternatives to corticosteroids.

How Tech-Driven Solutions, CMS Proposed Rule Can Save Rural Medicaid Members

In this second part of a two-part video series, Nathan Allen, Senior Vice President – Healthcare Provider Solutions at Firstsource, discusses Medicaid Redetermination for those who are Medicaid members, but are deemed to lose their coverage due to the upcoming expiration of COVID-19’s Public Health Emergency. Allen set a scope on Medicaid populations in rural settings and how they could be affected. However, there is hope through tech-based solutions and a proposed rule by CMS to prevent facility closures and preserve access to care for all affected Medicaid populations.

Medicaid Redetermination Solutions for Members Deemed to Lose Coverage From PHE Expiration

Nathan Allen, Senior Vice President – Healthcare Provider Solutions at Firstsource, discusses Medicaid Redetermination for those who are Medicaid members, but are deemed to lose their coverage due to the upcoming expiration of COVID-19’s Public Health Emergency.

Biomarkers for Graft-Versus-Host Disease | Part 2

Biomarkers can be used for many purposes — diagnosis, prognosis, projections for success of a treatment. Sophie Paczesny, M.D., Ph.D., a professor at the Hollings Cancer Center at the Medical University of South Carolina and an internationally recognized expert on biomarkers for graft-versus-host disease (GvHD), reviews a typology of biomarkers that groups them into five subtypes and discusses their use in GVHD.

Official Media Partners

PBMI logo

Join the Community

an mjh life sciences brand

© 2022 MJH Life Sciences and PBMI. All rights reserved.